awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36673751-30617628-E15E-4778-8750-C61D9DC33F74
Q36673751-30617628-E15E-4778-8750-C61D9DC33F74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-30617628-E15E-4778-8750-C61D9DC33F74
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
P2860
Q36673751-30617628-E15E-4778-8750-C61D9DC33F74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-30617628-E15E-4778-8750-C61D9DC33F74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80ea7c2cf7e7344ab33e97426c8f36d9e11982d8
P2860
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study